Hyperliquid Strategies INC
Market Movers (8-K)
Hyperliquid Strategies Inc. has entered into a new executive placement agreement for its COO and amended its CEO's employment contract.
Hyperliquid Strategies Inc. reported a significant net loss for Q2 2025, primarily driven by unrealized losses on HYPE tokens, despite strong balance sheet and strategic capital deployment.
Worse than expected
Capital raise
Hyperliquid Strategies Inc. announced a new stock repurchase program of up to $30 million, aiming to enhance shareholder value by increasing per-share exposure to the HYPE token.
Hyperliquid Strategies Inc. has completed its business combination with Sonnet BioTherapeutics and Rorschach I LLC, pivoting to a digital asset treasury model focused on the HYPE token and listing on Nasdaq under 'PURR'.
Capital raise
Quarterly Earnings (10-Q)
Hyperliquid Strategies Inc. reported a significant net loss for Q2 2025, driven by unrealized losses on HYPE digital assets and a large write-off from the Sonnet acquisition, despite substantial capital raises.
Capital raise
Worse than expected
Hyperliquid Strategies Inc. completed its business combination with Sonnet BioTherapeutics and Rorschach, raising significant capital and listing on Nasdaq, despite initial operating losses.
Capital raise
Insider Trading (Form 4)
Lawrence E. Leibowitz, a Director at Hyperliquid Strategies Inc., received 2,117 shares of common stock as compensation.
Eric S. Rosengren, a Director at Hyperliquid Strategies Inc., acquired 4,764 shares of common stock as compensation on July 1, 2026.
Director Thomas C. King acquired 4,764 shares of common stock in Hyperliquid Strategies Inc. as compensation.
Nailesh Bhatt, a Director at Hyperliquid Strategies Inc., acquired 1,588 shares of common stock as compensation.
Hyperliquid Strategies Inc. reports that Chief Operating Officer Jeroen Nieuwkoop, through SBR Limited, acquired 421,623 restricted stock units (RSUs) on June 23, 2026, as part of an executive placement agreement.
Hyperliquid Strategies Inc. CFO, Brett Douglas Beldner, was granted 421,623 restricted stock units on May 5, 2026, as part of his employment agreement.
New Public Companies (S-1)
Hyperliquid Strategies Inc. has filed an S-1/A amendment detailing the potential resale of up to 35,156,660 shares of common stock by Rorschach Advisors LLC.
Capital raise
Hyperliquid Strategies Inc has filed an amendment to its S-1 registration statement to facilitate the potential resale of up to 35.16 million shares of common stock by Rorschach Advisors LLC.
Capital raise
Hyperliquid Strategies Inc. has filed an amended S-1 registration statement detailing its business combination, financial position, and future plans.
Capital raise
Hyperliquid Strategies Inc. has entered into a $1.0 billion committed equity facility with Chardan Capital Markets LLC, enabling future stock sales to fund its HYPE token treasury strategy following a business combination.
Delay expected
Capital raise
Schedule 13G - Passive Investments
BlackRock, Inc. has reported a beneficial ownership of 7.3% in Hyperliquid Strategies Inc. common stock as of June 30, 2026.
D1 Capital Partners L.P. and Daniel Sundheim have reported a 6.3% passive beneficial ownership stake in Hyperliquid Strategies Inc. common stock.
Rorschach Capital LLC has significantly reduced its beneficial ownership in Hyperliquid Strategies Inc. from 5.18% to 0.05%.
Worse than expected
Rorschach Advisors LLC has reported a 9.99% beneficial ownership stake in Hyperliquid Strategies Inc. following a business combination and warrant issuance.
Capital raise